<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719020</article-id><article-id pub-id-type="pmc">6852446</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0309</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Botulinum Toxin Injection into Epicardial Fat Pads: A Promising
Potential Modality for Prevention of Postoperative Atrial Fibrillation After
Cardiac Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3284-4959</contrib-id><name><surname>Fatahian</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><aff id="aff1">
<label>1</label>Department of Cardiology, Faculty of Medicine, Mazandaran
University of Medical Sciences, Sari, Iran.</aff></contrib-group><author-notes><corresp id="c1">E-mail: <email>drafatahian@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>643</fpage><lpage>643</lpage><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions></article-meta></front><body><p>Despite developing new standards and advances in anesthetic and surgical techniques,
postoperative atrial fibrillation (POAF) is one of the most frequent complications and a
significant unsolved clinical problem after cardiac surgery<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Occurrence of POAF is associated with significant
increased risk of long-term mortality, morbidity, and long intensive care unit (ICU) and
hospital stays, which consequently impose additional cost on both health system and
patient<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Considering the
potential significant adverse effects of POAF in patients undergoing cardiac surgery and
the limited efficacy of current preventive strategies, concerted efforts to identify and
implement new preventive strategies are necessary<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>Recently, injection of botulinum toxin into epicardial fat pads in patients undergoing
cardiac surgery has been suggested as a promising modality for prevention of POAF. In a
study by Pokushalov et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, it has
been shown that 50 U botulinum toxin injection, at four major epicardial fat pads,
during surgery in patients undergoing coronary artery bypass grafting (CABG) provided
considerable atrial tachyarrhythmia suppression, in both early and one-year
follow-ups<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Also, a
three-year follow-up of this study indicates a sustained and significant reduction in
atrial fibrillation (AF) incidence and burden, along with reduction in patients'
hospitalizations. Besides, no serious adverse events related to injection of botulinum
toxin for prevention of POAF after CABG have been reported<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Suppression of atrial autonomic remodeling has been
suggested as a potential mechanism of botulinum toxin injection for prevention of
POAF<sup>[<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Another study by Waldron et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> showed that injection of 50 U of botulinum toxin into
each five epicardial fat pads (immediately after beginning of cardiopulmonary bypass) in
patients undergoing cardiac surgery reduced the incidence of POAF compared to placebo
(36.5% and 47.8%, respectively), however this difference was not statistically
significant. Also, no significant differences were seen between length of hospital stay
and occurrence of adverse effects in patients who received botulinum toxin injection or
placebo<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. In this study,
patients who underwent CABG or valve surgery or combined CABG and valve surgery were
included; whereas in Pokushalov et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> one-year and three-year follow-up studies<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>, only CABG patients were included and
evaluated. Additionally, the left atrial sizes, as a marker of atrial structural
remodeling, which commonly is associated with increased risk for AF, were considerably
different between these studies (3.9&#x000b1;0.6 and 3.9&#x000b1;0.7 cm
<italic>vs</italic>. 4.7&#x000b1;0.8 and 4.8&#x000b1;0.6, respectively). These issues
may be possible explanations for the inconsistent results between studies. In sum, it
seems that botulinum toxin injection into epicardial fat pads may be considered as a
potentially promising and safe modality for prevention of POAF after cardiac surgery.
However, further well-designed studies will be required to investigate the efficacy of
this preventive modality for POAF in patients undergoing cardiac surgery, after
controlling the potential confounding factors such as type of surgery, left atrial
sizes, dose and site of injection of botulinum toxin, etc.</p></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>JW</given-names></name><name><surname>Lancaster</surname><given-names>TS</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Melby</surname><given-names>SJ</given-names></name></person-group><article-title>Postoperative atrial fibrillation following cardiac surgery: a
persistent complication</article-title><source>Eur J Cardiothorac Surg</source><year>2017</year><volume>52</volume><issue>4</issue><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezx039</pub-id><pub-id pub-id-type="pmid">28369234</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimani</surname><given-names>A</given-names></name><name><surname>Habibi</surname><given-names>MR</given-names></name><name><surname>Hasanzadeh Kiabi</surname><given-names>F</given-names></name><name><surname>Alipour</surname><given-names>A</given-names></name><name><surname>Habibi</surname><given-names>V</given-names></name><name><surname>Azizi</surname><given-names>S</given-names></name><etal/></person-group><article-title>The effect of intravenous N-acetylcysteine on prevention of
atrial fibrillation after coronary artery bypass graft surgery: a
double-blind, randomised, placebo-controlled trial</article-title><source>Kardiol Pol</source><year>2018</year><volume>76</volume><issue>1</issue><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.5603/KP.a2017.0183</pub-id><pub-id pub-id-type="pmid">28980294</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokushalov</surname><given-names>E</given-names></name><name><surname>Kozlov</surname><given-names>B</given-names></name><name><surname>Romanov</surname><given-names>A</given-names></name><name><surname>Strelnikov</surname><given-names>A</given-names></name><name><surname>Bayramova</surname><given-names>S</given-names></name><name><surname>Sergeevichev</surname><given-names>D</given-names></name><etal/></person-group><article-title>Long-term suppression of atrial fibrillation by botulinum toxin
injection into epicardial fat pads in patients undergoing cardiac surgery:
one-year follow-up of a randomized pilot study</article-title><source>Circ Arrhythm Electrophysiol</source><year>2015</year><volume>8</volume><issue>6</issue><fpage>1334</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1161/CIRCEP.115.003199</pub-id><pub-id pub-id-type="pmid">26486855</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanov</surname><given-names>A</given-names></name><name><surname>Pokushalov</surname><given-names>E</given-names></name><name><surname>Ponomarev</surname><given-names>D</given-names></name><name><surname>Bayramova</surname><given-names>S</given-names></name><name><surname>Shabanov</surname><given-names>V</given-names></name><name><surname>Losik</surname><given-names>D</given-names></name><etal/></person-group><article-title>Long-term suppression of atrial fibrillation by botulinum toxin
injection into epicardial fat pads in patients undergoing cardiac surgery:
three-year follow-up of a randomized study</article-title><source>Heart Rhythm</source><year>2019</year><volume>16</volume><issue>2</issue><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2018.08.019</pub-id><pub-id pub-id-type="pmid">30414841</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldron</surname><given-names>NH</given-names></name><name><surname>Cooter</surname><given-names>M</given-names></name><name><surname>Haney</surname><given-names>JC</given-names></name><name><surname>Schroder</surname><given-names>JN</given-names></name><name><surname>Gaca</surname><given-names>JG</given-names></name><name><surname>Lin</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Temporary autonomic modulation with botulinum toxin type A to
reduce atrial fibrillation after cardiac surgery</article-title><source>Heart Rhythm</source><year>2019</year><volume>16</volume><issue>2</issue><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2018.08.021</pub-id><pub-id pub-id-type="pmid">30414840</pub-id></element-citation></ref></ref-list></back></article>